Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant-Reference-Cited by-同舟云学术

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

Published:1999-08 Issue:23-24 Volume:17 Page:3145-3159
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Saul Allan,Lawrence Gregor,Smillie Anne,Rzepczyk Christine M.,Reed Carol,Taylor Darrin,Anderson Karen,Stowers Anthony,Kemp Richard,Allworth Anthony,Anders Robin F.,Brown Graham V.,Pye David,Schoofs Peter,Irving David O.,Dyer Shanny L.,Woodrow Graeme C.,Briggs William R.S.,Reber Rosemaria,Stürchler Dieter

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Progress on vaccines against parasites;Engers;Dev Biol Stand,1996

2. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720;Lawrence;Vaccine,1997

3. Immunization against blood-stage rodent malaria using purified parasite antigens;Holder;Nature,1981

4. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria;Siddiqui;Proc Natl Acad Sci USA,1987

5. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1;Cooper;Mol Biochem Parasitol,1992

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate;Expert Review of Vaccines;2023-12-27

2. Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine;Trends in Parasitology;2023-11

3. Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA);Frontiers in Immunology;2022-09-22

4. Future use-cases of vaccines in malaria control and elimination;Parasite Epidemiology and Control;2020-08

5. Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1;Vaccine;2019-08